REPLOGLE JOHN B

Director John B Replogle bought 3,000 shares of CROX at $74.50 on 2025-11-11 for $223,500; stock down 38.1% from 52-week high.

John B Replogle, a Director, purchased 3,000 shares of Crocs at $74.50, bringing his total holdings to 18,417 shares—a 19.5% increase in position size. The purchase occurred as CROX trades 38.1% below its 52-week high of $120.26 and has declined 8.6% over the past 30 days. Replogle's prior trades at CROX show mixed timing: 3 of 5 prior buys were well-timed at the 90-day mark, with results ranging from +24.2% to -13.0%. His cross-ticker track record shows an average 90-day return of +3.8% with a 55.56% win rate. The company's fundamentals show revenue of $996.3M and net income of $145.8M in the latest quarter, with annual growth of 3.5% and a P/E of 21.15. The current market conditions present a meaningful valuation shift from the 52-week peak, though near-term momentum remains negative.

Director Replogle purchases 3,261 CROX shares in 2 transactions for $250,084.42 ($76.69 avg) as stock down -28.9% in 90 days

JOHN B REPLOGLE, Director at Crocs, made 2 separate open-market purchases totaling 3,261 shares at a blended average price of $76.69, increasing his holdings by 26.8% to 15,417 shares post-transaction. The purchases occurred as CROX trades at $83.40 (current), down -28.9% over 90 days and -43.4% from its 52-week high of $147.40, creating a substantially cheaper entry point than recent historical levels. However, Replogle's prior buy history at this ticker shows mixed near-term outcomes: his 3 previous CROX purchases had 30-day returns of -6.2%, +17.9%, and -1.0%, with only 1 of 3 achieving positive 90-day returns, suggesting timing precision at this equity has been inconsistent despite the current valuation discount.

Director Replogle buys 42,735 shares of GROV at $1.18; cluster of 3 insider buys in 14 days despite -21.5% annual revenue decline and unprofitability

John B Replogle, a director, purchased 42,735 shares of Grove Collaborative Holdings on 2025-05-21 at $1.18, bringing his holdings to 497,859 shares post-transaction and representing a 9.4% increase in his position. This purchase is part of a cluster pattern: 2 other insiders also bought within the past 14 days. However, this activity occurs in a materially challenged context: the company reported annual revenue growth of -21.5% and was unprofitable over its most recent full fiscal year with a net loss of $3,547,000.00. Additionally, Replogle's prior buy at GROV on 2024-03-11 resulted in a -18.1% return over 90 days, and across his cross-ticker track record, his 6 prior buys averaged only a +1.0% 90-day return with a 33.33% win rate. The stock is currently at $1.18, down 35.9% from its 52-week high and down 28.9% over 90 days, suggesting concentrated buying pressure at depressed levels coincides with deteriorating financial fundamentals.

Director Replogle buys 2,240 CROX shares at $112.60, raising stake 31.7% to 9,304 shares

Director John B Replogle purchased 2,240 shares of Crocs at $112.60 on 2024-10-30, expanding his holdings by 31.7% from 7,064 to 9,304 shares. The purchase occurs as the stock trades at $109.00, down 24.7% over the prior 30 days and 31.7% below the 52-week high of $159.68, yet the company maintains a low P/E of 7.61 with strong fundamentals: $1.1B quarterly revenue, $199.8M net income, and 11.5% annual revenue growth. His prior open-market buy at this ticker on 2024-08-02 returned +17.9% within 30 days, and his buy on 2024-03-14 returned +24.2% over 90 days, establishing a track record of well-timed entry points at CROX; however, his cross-ticker average 90-day return of +6.8% (50% win rate across 5 prior buys) is modest, and this current purchase follows a sharp 30-day drawdown that warrants scrutiny as to whether the timing reflects genuine conviction or opportunistic accumulation into weakness.

CROX director Replogle purchases 1,996 shares for $247.4K at $123.96, growing holdings 39.4%; stock down 24.2% from 52-week high

Director John B Replogle bought 1,996 shares of Crocs at $123.96 on 2024-08-02, expanding his holdings by 39.4% to 7,064 shares. The purchase occurred against a backdrop of weakness: the stock trades at $121.05 currently, down 24.2% from its 52-week high of $159.68 and down 15.7% over the prior 30 days. Notably, Replogle's prior buy at CROX on 2024-03-14 delivered a 90-day return of +24.2%, demonstrating successful timing on that occasion. The company's fundamentals remain solid—P/E of 8.86, annual revenue growth of +11.5%, and quarterly net income of $228.9M—though the valuation compression and recent price decline may have created the opportunity for this discretionary open-market accumulation.